COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,617 Articles (22,913 medRxiv, 8,704 bioRxiv)

Most recent first Previous |  Page 12: Articles 111-120  | Next

SARS CoV 2 Associated Shifts in the Upper Respiratory Tract Mycobiome in Non Hospitalized Cases
Tomar, S. S., Khairnar, K.
10.64898/2026.05.07.26352639 — Posted: 2026-05-10
Delayed humoral kinetics but stabilization of IgG responses in common variable immunodeficiency after SARS-CoV-2 mRNA booster vaccination
Federico, L., Loeken, R. O., Quy, K. L., Osen, J. R., Chaban, V., Nordoey, I., Skarpengland, T., Lundin, K. E., Fjellgaard Joergensen, S., Fraz, M. S. A., Aukrust, P., Lund, K. P., Tran, T. T., Nygaard Osnes, L. T., Lund-Johansen, F., Kared, H., Fevang, B., Munthe, L. A.
10.64898/2026.05.07.26352649 — Posted: 2026-05-08
Positive Registration Rate as a Key Determinant of COCOA Effectiveness: Empirical Evidence from Individual-Level Key-Match Data during the Sixth and Seventh COVID-19 Waves in Japan
Nakagawa, S., Kumagai, S., Yamamoto, A.
10.64898/2026.05.06.26352506 — Posted: 2026-05-08
Safety first: should the high tolerability of intramuscular anti-spike COVID-19 monoclonal antibody change our expectations of vaccine safety?
Putrino, D., Curtis, A., Leston, M., Yalcin, I., Gerlach, R., Elia, M., Mina, M.
10.64898/2026.05.08.26352596 — Posted: 2026-05-08
The Effect of Vaccination on the Evolution of the SARS-CoV-2 B.1.351 Variant
Wang, Z., Raeihle, M., Braun-Gorman, S., Leung, I., Richards, C., Gabbay, L., Shamoon-Pour, M.
10.64898/2026.05.06.723356 — Posted: 2026-05-08
Site-Specific Entry Factors Define Cellular Susceptibility to SARS-CoV-2 in Human Tissues
Vivas-Roca, M., Mancebo-Perez, C., Abdalfttah, M., Balafkir, I., Benitez-Martinez, A., Montal, V., Gonzalez, A., Mota-Gomez, I., Grau-Exposito, J., Pieren, D. K., Planas, B., Rosado, J., Semidey, M. E., Landolfi, S., Espin-Bassany, E., Trilla, E., Falco, V., Curran, A., Burgos, J., Buzon, M. J., Guallar, V., Heyn, H., Genesca, M.
10.64898/2026.05.07.723425 — Posted: 2026-05-08
Helminth-remodeled microbial indole-3-lactic acid drives AhR-dependent disease tolerance
Sun, R., Liu, Y., Wang, Y., Xu, N., Ma, X., Lv, Q., Zhao, X., Vallee, I., Boireau, P., Wu, Z., Liu, M., Liu, X., Jin, X.
10.64898/2026.05.06.723221 — Posted: 2026-05-08
vartracker: an end-to-end tool for pathogen longitudinal variant analysis and visualisation
Foster, C. S. P., Rawlinson, W. D.
10.64898/2026.05.06.723370 — Posted: 2026-05-08
Determinants and long-term outcomes of COVID-19 undervaccination: a cohort study of 6.8 million individuals in Lombardy, Italy
Corbetta, A., Logan, K. M., Ieva, F., Di Angelantonio, E.
10.64898/2026.05.06.26352509 — Posted: 2026-05-07
SARS-CoV-2 Nsp2 reprograms host immunity to drive pathogenic inflammation
Lacasse, E., Dubuc, I., Leclerc, J., Gravel, A., Gudimard, L., Joly-Beauparlant, C., Faure, M., Fortin, P., Blanchet, M.-R., Droit, A., Flamand, L.
10.64898/2026.05.06.723222 — Posted: 2026-05-07

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).